Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

Circulating antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload in heart failure. This study aimed to evaluate the effect of dapagliflozin on short-term CA125 levels in patients with stable heart failure with reduced ejection fraction (HFrEF) and whether these changes mediated...

Descripción completa

Detalles Bibliográficos
Autores principales: Amiguet, Martina, Palau, Patricia, Domínguez, Eloy, Seller, Julia, Pinilla, Jose Manuel Garcia, de la Espriella, Rafael, Miñana, Gema, Valle, Alfonso, Sanchis, Juan, Górriz, Jose Luis, Bayés-Genís, Antoni, Núñez, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313805/
https://www.ncbi.nlm.nih.gov/pubmed/37391470
http://dx.doi.org/10.1038/s41598-023-37491-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313805/
https://www.ncbi.nlm.nih.gov/pubmed/37391470
http://dx.doi.org/10.1038/s41598-023-37491-5

Ejemplares similares